Direct Estimation for Commonly Used Pattern-Mixture Models in Clinical Trials
- 19 December 2024
- journal article
- research article
- Published by Taylor & Francis in Statistics in Biopharmaceutical Research
- Vol. 17 (3) , 404-416
Abstract
No abstract availableKeywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Statistical methods for handling missing data to align with treatment policy strategyPharmaceutical Statistics, 2023
- Return‐to‐baseline multiple imputation for missing values in clinical trialsPharmaceutical Statistics, 2022
- Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 PandemicTherapeutic Innovation & Regulatory Science, 2021
- Defining estimands using a mix of strategies to handle intercurrent events in clinical trialsPharmaceutical Statistics, 2020
- The attributable estimand: A new approach to account for intercurrent eventsPharmaceutical Statistics, 2020
- A Likelihood-Based Approach for the Analysis of Longitudinal Clinical Trials with Return-to-Baseline ImputationStatistics in Biosciences, 2020
- Reference‐based multiple imputation for missing data sensitivity analyses in trial‐based cost‐effectiveness analysisHealth Economics, 2019
- Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative StudyJournal of the American Statistical Association, 2019
- Missing data in clinical trials: control‐based mean imputation and sensitivity analysisPharmaceutical Statistics, 2017
- Causal Inference for Statistics, Social, and Biomedical Sciences2015